Clinical trial NCT01607073 - References

Dravet Syndrome — Verapamil as Therapy for Children and Young Adults With Dravet Syndrome

Citation(s)

•   Abernethy DR, Egan JM, Dickinson TH, Carrum G
  Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans. J Pharmacol Exp Ther. 1988 Mar;244(3):994-9.
•   Allen LV Jr, Erickson MA 3rd
  Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids. Am J Health Syst Pharm. 1996 Oct 1;53(19):2304-9.
•   Backman JT, Olkkola KT, Aranko K, Himberg JJ, Neuvonen PJ
  Dose of midazolam should be reduced during diltiazem and verapamil treatments. Br J Clin Pharmacol. 1994 Mar;37(3):221-5.
•   Brogden RN, Heel RC, Speight TM, Avery GS
  Clobazam: a review of its pharmacological properties and therapeutic use in anxiety. Drugs. 1980 Sep;20(3):161-78. Review.
•   Chiron C, Marchand MC, Tran A, Rey E, d'Athis P, Vincent J, Dulac O, Pons G
  Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet. 2000 Nov 11;356(9242):1638-42.
•   Contin M, Riva R, Albani F, Baruzzi AA
  Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy. Ther Drug Monit. 1999 Dec;21(6):604-8.
•   Delogu AB, Spinelli A, Battaglia D, Dravet C, De Nisco A, Saracino A, Romagnoli C, Lanza GA, Crea F
  Electrical and autonomic cardiac function in patients with Dravet syndrome. Epilepsia. 2011 Apr;52 Suppl 2:55-8. doi: 10.1111/j.1528-1167.2011.03003.x.
•   Edwards DJ, Lavoie R, Beckman H, Blevins R, Rubenfire M
  The effect of coadministration of verapamil on the pharmacokinetics and metabolism of quinidine. Clin Pharmacol Ther. 1987 Jan;41(1):68-73.
•   Ferri R, Curzi-Dascalova L, Arzimanoglou A, Bourgeois M, Beaud C, Nunes ML, Elia M, Musumeci SA, Tripodi M
  Heart rate variability during sleep in children with partial epilepsy. J Sleep Res. 2002 Jun;11(2):153-60.
•   Fleishaker JC, Sisson TA, Carel BJ, Azie NE
  Pharmacokinetic interaction between verapamil and almotriptan in healthy volunteers. Clin Pharmacol Ther. 2000 May;67(5):498-503.
•   Flynn JT, Pasko DA
  Calcium channel blockers: pharmacology and place in therapy of pediatric hypertension. Pediatr Nephrol. 2000 Dec;15(3-4):302-16. Review.
•   Forslund L, Björkander I, Ericson M, Held C, Kahan T, Rehnqvist N, Hjemdahl P
  Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris. Heart. 2002 May;87(5):415-22.
•   Giraud C, Tran A, Rey E, Vincent J, Tréluyer JM, Pons G
  In vitro characterization of clobazam metabolism by recombinant cytochrome P450 enzymes: importance of CYP2C19. Drug Metab Dispos. 2004 Nov;32(11):1279-86.
•   Giraud C, Treluyer JM, Rey E, Chiron C, Vincent J, Pons G, Tran A
  In vitro and in vivo inhibitory effect of stiripentol on clobazam metabolism. Drug Metab Dispos. 2006 Apr;34(4):608-11. Epub 2006 Jan 13.
•   Greenblatt DJ, Divoll M, Puri SK, Ho I, Zinny MA, Shader RI
  Clobazam kinetics in the elderly. Br J Clin Pharmacol. 1981 Nov;12(5):631-6.
•   Iannetti P, Parisi P, Spalice A, Ruggieri M, Zara F
  Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy. Epilepsy Res. 2009 Jul;85(1):89-95. doi: 10.1016/j.eplepsyres.2009.02.014. Epub 2009 Mar 20.
•   Inoue Y, Ohtsuka Y, Oguni H, Tohyama J, Baba H, Fukushima K, Ohtani H, Takahashi Y, Ikeda S
  Stiripentol open study in Japanese patients with Dravet syndrome. Epilepsia. 2009 Nov;50(11):2362-8. doi: 10.1111/j.1528-1167.2009.02179.x. Epub 2009 Jun 22.
•   Jawad S, Richens A, Oxley J
  Single dose pharmacokinetic study of clobazam in normal volunteers and epileptic patients. Br J Clin Pharmacol. 1984 Dec;18(6):873-7.
•   Kantola T, Kivistö KT, Neuvonen PJ
  Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations. Clin Pharmacol Ther. 1998 Aug;64(2):177-82.
•   Lamberg TS, Kivistö KT, Neuvonen PJ
  Effects of verapamil and diltiazem on the pharmacokinetics and pharmacodynamics of buspirone. Clin Pharmacol Ther. 1998 Jun;63(6):640-5.
•   Lampl C
  Childhood-onset cluster headache. Pediatr Neurol. 2002 Aug;27(2):138-40.
•   Lefrandt JD, Heitmann J, Sevre K, Castellano M, Hausberg M, Fallon M, Fluckiger L, Urbigkeit A, Rostrup M, Agabiti-Rosei E, Rahn KH, Murphy M, Zannad F, de Kam PJ, van Roon AM, Smit AJ
  The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE study. Am J Hypertens. 2001 Nov;14(11 Pt 1):1083-9.
•   May A, Leone M, Afra J, Linde M, Sándor PS, Evers S, Goadsby PJ; EFNS Task Force
  EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol. 2006 Oct;13(10):1066-77.
•   Motte J, Trevathan E, Arvidsson JF, Barrera MN, Mullens EL, Manasco P
  Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. N Engl J Med. 1997 Dec 18;337(25):1807-12. Erratum in: N Engl J Med 1998 Sep 17;339(12):851-2.
•   Mukherjee S, Tripathi M, Chandra PS, Yadav R, Choudhary N, Sagar R, Bhore R, Pandey RM, Deepak KK
  Cardiovascular autonomic functions in well-controlled and intractable partial epilepsies. Epilepsy Res. 2009 Aug;85(2-3):261-9. doi: 10.1016/j.eplepsyres.2009.03.021. Epub 2009 May 5.
•   Neels HM, Sierens AC, Naelaerts K, Scharpé SL, Hatfield GM, Lambert WE
  Therapeutic drug monitoring of old and newer anti-epileptic drugs. Clin Chem Lab Med. 2004;42(11):1228-55. Review.
•   Petretta M, Canonico V, Madrid A, Mickiewicz M, Spinelli L, Marciano F, Vetrano A, Signorini A, Bonaduce D
  Comparison of verapamil versus felodipine on heart rate variability in hypertensive patients. J Hypertens. 1999 May;17(5):707-13.
•   Porter CJ, Garson A Jr, Gillette PC
  Verapamil: an effective calcium blocking agent for pediatric patients. Pediatrics. 1983 May;71(5):748-55. Review.
•   Renton KW
  Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil. Biochem Pharmacol. 1985 Jul 15;34(14):2549-53.
•   Sapire DW, O'Riordan AC, Black IF
  Safety and efficacy of short- and long-term verapamil therapy in children with tachycardia. Am J Cardiol. 1981 Dec;48(6):1091-7.
•   Schwartz JB, Keefe DL, Kirsten E, Kates RE, Harrison DC
  Prolongation of verapamil elimination kinetics during chronic oral administration. Am Heart J. 1982 Aug;104(2 Pt 1):198-203.
•   Sirmans SM, Pieper JA, Lalonde RL, Smith DG, Self TH
  Effect of calcium channel blockers on theophylline disposition. Clin Pharmacol Ther. 1988 Jul;44(1):29-34.
•   Skluzacek JV, Watts KP, Parsy O, Wical B, Camfield P
  Dravet syndrome and parent associations: the IDEA League experience with comorbid conditions, mortality, management, adaptation, and grief. Epilepsia. 2011 Apr;52 Suppl 2:95-101. doi: 10.1111/j.1528-1167.2011.03012.x.
•   Stringer KA, Mallet J, Clarke M, Lindenfeld JA
  The effect of three different oral doses of verapamil on the disposition of theophylline. Eur J Clin Pharmacol. 1992;43(1):35-8.
•   Wang YH, Jones DR, Hall SD
  Prediction of cytochrome P450 3A inhibition by verapamil enantiomers and their metabolites. Drug Metab Dispos. 2004 Feb;32(2):259-66.
•   Yang TF, Wong TT, Chang KP, Kwan SY, Kuo WY, Lee YC, Kuo TB
  Power spectrum analysis of heart rate variability in children with epilepsy. Childs Nerv Syst. 2001 Oct;17(10):602-6.

Verapamil as Adjunctive Seizure Therapy for Children and Young Adults With Dravet Syndrome

Details for clinical trial NCT01607073